Related references
Note: Only part of the references are listed.Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study
M. S. M. Persson et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Genetic predisposition to bullous pemphigoid
Jieyu Zhang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2020)
Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002-2016
Aimin Yang et al.
DIABETES CARE (2020)
From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
Juliana C. N. Chan et al.
DIABETES CARE (2019)
HLA-DQB1*03:01 as a Biomarker for Genetic Susceptibility to Bullous Pemphigoid Induced by DPP-4 Inhibitors
Hideyuki Ujiie et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Second-generation PLINK: rising to the challenge of larger and richer datasets
Christopher C. Chang et al.
GIGASCIENCE (2015)
Mortality Rate in Bullous Pemphigoid: A Retrospective Monocentric Cohort Study
B. Cortes et al.
DERMATOLOGY (2012)
Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
K. Skandalis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Gene map of the extended human MHC
R Horton et al.
NATURE REVIEWS GENETICS (2004)
Share Paper
